1,2-distearoyllecithin has been researched along with boron in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bauer, WF; Feakes, DA; Hawthorne, MF; Krisch, TA; Schmidt, PG; Shelly, K | 1 |
Ban, HS; Nakamura, H; Tachikawa, S; Ueda, N; Ueno, M | 1 |
2 other study(ies) available for 1,2-distearoyllecithin and boron
Article | Year |
---|---|
Model studies directed toward the boron neutron-capture therapy of cancer: boron delivery to murine tumors with liposomes.
Topics: Animals; Boron; Boron Neutron Capture Therapy; Drug Carriers; Hydrolysis; Liposomes; Magnetic Resonance Spectroscopy; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Molecular Conformation; Phosphatidylcholines; Tissue Distribution | 1992 |
Design and synthesis of fluorescence-labeled closo-dodecaborate lipid: its liposome formation and in vivo imaging targeting of tumors for boron neutron capture therapy.
Topics: Animals; Boron; Boron Compounds; Drug Delivery Systems; Female; Fluorescence; Liposomes; Mice; Neoplasms; Oxadiazoles; Phosphatidylcholines; Phosphatidylethanolamines; Polyethylene Glycols; Stearates; Tissue Distribution | 2012 |